HAL-MPE1 Safety and Tolerability Study
Clinical trial NCT02991885 · COMPLETED
Trial details
- NCT number
- NCT02991885
- Sponsor
- HAL Allergy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-04-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.